Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas

Gene

Volumn 528, Issue 2, 2013, Pages 146-153

  Wang, Hongliang ^a   Li, Ping ^a   Zhao, Bing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Migration; NOB1; Proliferation; RNAi

Indexed keywords

LENTIVIRUS VECTOR; MESSENGER RNA; NOB1 PROTEIN; RIBOSOME PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CANCER GRADING; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 8 BINDING PROTEIN 1; 3,3′-DIAMINOBENZIDINE; AMERICAN TYPE CULTURE COLLECTION; ATCC; BCA; BICINCHONINIC ACID; BOVINE SERUM ALBUMIN; BSA; DAB; DMEM; DULBECCO'S MODIFIED EAGLE'S MEDIUM; FACS; FBS; FETAL BOVINE SERUM; FLUORESCENCE-ACTIVATED CELL SORTING; GAPDH; GFP; GLIOMA; GLYCERALDEHYDE3-PHOSPHATE DEHYDROGENASE; GREEN FLUORESCENT PROTEIN; HEK; HOMOLOGUES OF THE PILT N-TERMINAL DOMAIN; HUMAN EMBRYONIC KIDNEY; IHC; IMMUNOHISTOCHEMISTRY; M-MLV REVERSE TRANSCRIPTASE; M-MLV-RT; METHYLTHIAZOLETETRAZOLIUM; MIGRATION; MOI; MTT; MULTIPLICITY OF INFECTION; NIN1/RPN12 BINDING PROTEIN 1 HOMOLOG; NOB1; PI; PIN DOMAIN; PROLIFERATION; PROPIDIUM IODIDE; PSMD8BP1; RNA INTERFERENCE; RNAI; SHORT-HAIRPIN RNA; SHRNA; SIRNA; SMALL INTERFERING RNA; TETRAETHYL RHODAMINE ISOTHIOCYANATE; TRITC; WHO; WORLD HEALTH ORGANIZATION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; NUCLEAR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS;

LENTIVIRUS;

EID: 84883049184     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.032     Document Type: Article

References (31)

1. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553.
2. Busa R., Paronetto M.P., Farini D., Pierantozzi E., Botti F., Angelini D.F., Attisani F., Vespasiani G., Sette C. The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene 2007, 26:4372-4382.
3. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
4. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
5. Fatica A., Oeffinger M., Dlakic M., Tollervey D. Nob1p is required for cleavage of the 3' end of 18S rRNA. Mol. Cell. Biol. 2003, 23:1798-1807.
6. Fatica A., Tollervey D., Dlakic M. PIN domain of Nob1p is required for D-site cleavage in 20S pre-rRNA. RNA 2004, 10:1698-1701.
7. Guo D., Wang B., Han F., Lei T. RNA interference therapy for glioblastoma. Expert. Opin. Biol. Ther. 2010, 10:927-936.
8. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
9. Lamanna A.C., Karbstein K. Nob1 binds the single-stranded cleavage site D at the 3'-end of 18S rRNA with its PIN domain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14259-14264.
10. Lamanna A.C., Karbstein K. An RNA conformational switch regulates pre-18S rRNA cleavage. J. Mol. Biol. 2011, 405:3-17.
11. Lin Y., Peng S., Yu H., Teng H., Cui M. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med. Oncol. 2012, 29:311-317.
12. Liu B.L., Cheng J.X., Zhang X., Zhang W. Controversies concerning the application of brachytherapy in central nervous system tumors. J. Cancer Res. Clin. Oncol. 2010, 136:173-185.
13. Liu L., Wu J., Ying Z., Chen B., Han A., Liang Y., Song L., Yuan J., Li J., Li M. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res. 2010, 70:3750-3759.
14. Lu Z., Guo Q., Shi A., Xie F., Lu Q. Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol. Biol. Rep. 2012, 39:501-507.
15. Mani A., Gelmann E.P. The ubiquitin-proteasome pathway and its role in cancer. J. Clin. Oncol. 2005, 23:4776-4789.
16. Micel L.N., Tentler J.J., Smith P.G., Eckhardt G.S. Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J. Clin. Oncol. 2013, 31:1231-1238.
17. Montanaro L., Trere D., Derenzini M. Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim. Biophys. Acta 2012, 1825:101-110.
18. Nazar R.N. Ribosomal RNA processing and ribosome biogenesis in eukaryotes. IUBMB Life 2004, 56:457-465.
19. Oehler V.G., Yeung K.Y., Choi Y.E., Bumgarner R.E., Raftery A.E., Radich J.P. The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data. Blood 2009, 114:3292-3298.
20. Pecot C.V., Calin G.A., Coleman R.L., Lopez-Berestein G., Sood A.K. RNA interference in the clinic: challenges and future directions. Nat. Rev. Cancer 2011, 11:59-67.
21. Pertschy B., Schneider C., Gnadig M., Schafer T., Tollervey D., Hurt E. RNA helicase Prp43 and its co-factor Pfa1 promote 20 to 18S rRNA processing catalyzed by the endonuclease Nob1. J. Biol. Chem. 2009, 284:35079-35091.
22. Pollo B. Neuropathological diagnosis of brain tumours. Neurol. Sci. 2011, 32(Suppl. 2):S209-S211.
23. Senft C., Priester M., Polacin M., Schroder K., Seifert V., Kogel D., Weissenberger J. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J. Neurooncol. 2011, 101:393-403.
24. Strunk B.S., Loucks C.R., Su M., Vashisth H., Cheng S., Schilling J., Brooks C.L., Karbstein K., Skiniotis G. Ribosome assembly factors prevent premature translation initiation by 40S assembly intermediates. Science 2011, 333:1449-1453.
25. Stupp R., Mason W.P., Van Den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
26. Tone Y., Toh E.A. Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae. Genes Dev. 2002, 16:3142-3157.
27. Tone Y., Tanahashi N., Tanaka K., Fujimuro M., Yokosawa H., Toh-e A. Nob1p, a new essential protein, associates with the 26S proteasome of growing saccharomyces cerevisiae cells. Gene 2000, 243:37-45.
28. Veith T., Martin R., Wurm J.P., Weis B.L., Duchardt-Ferner E., Safferthal C., Hennig R., Mirus O., Bohnsack M.T., Wohnert J., Schleiff E. Structural and functional analysis of the archaeal endonuclease Nob1. Nucleic Acids Res. 2012, 40:3259-3274.
29. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.
30. Zhang Y., Ni J., Zhou G., Yuan J., Ren W., Shan Y., Tang W., Yu L., Zhao S. Cloning, expression and characterization of the human NOB1 gene. Mol. Biol. Rep. 2005, 32:185-189.
31. Zhou Y., Su Z., Huang Y., Sun T., Chen S., Wu T., Chen G., Xie X., Li B., Du Z. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J. Exp. Clin. Cancer Res. 2011, 30:114.